Immunocytochemical and morphometric study of TSH, PRL, GH, and ACTH cells in Bufo arenarum larvae with inhibited thyroid function.
Changes in the pituitary cells involved in amphibian metamorphosis were studied in Bufo arenarum tadpoles with inhibited thyroid function. After hatching, larvae were treated for 5 months with potassium perchlorate (KClO4), a goitrogenic substance known to prevent absorption of iodine from water or food, resulting in impaired thyroid hormone synthesis. Treated larvae continued to grow but halted their development in premetamorphosis, showing hyperplastic thyroid glands with disorganized follicles lacking colloid. Thyrotrop (TSH), lactotrop (PRL), somatotrop (GH), and corticotrop (ACTH) cells were stained immunocytochemically and the changes observed were evaluated morphometrically using an automatic image analyzer. Pars distalis volume increased in treated larvae. Morphometric results showed that, in treated tadpoles, TSH and PRL cell populations and cell volumes increased compared to normal larvae at the same stage. Changes in the GH and ACTH cell morphometry were slight. These results indicate that in Bufo tadpoles, after chronic thyroid hormone withdrawal, TSH, PRL, GH, and ACTH cells are able to develop and that thyroid hormones exert a strong feedback control on the synthesis and storage of TSH and PRL.
Miranda
L A
LA
Laboratorio de Investigaciones Embriológicas (CONICET), Buenos Aires, Argentina.
Paz
D A
DA
Dezi
R E
RE
Pisanó
A
A
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000818:Animals; D002022:Bufo arenarum / Q000254:growth & development* / Q000378:metabolism; D002452:Cell Count; D048429:Cell Size; D005246:Feedback; D005260:Female; D013006:Growth Hormone / Q000378:metabolism; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism* / Q000473:pathology; D007037:Hypothyroidism / Q000139:chemically induced / Q000378:metabolism; D007091:Image Processing, Computer-Assisted; D007150:Immunohistochemistry; D007814:Larva / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008675:Metamorphosis, Biological / Q000187:drug effects / Q000502:physiology*; D009479:Neuropeptides / Q000378:metabolism*; D010472:Perchlorates / Q000494:pharmacology; D017680:Potassium Compounds / Q000494:pharmacology; D011388:Prolactin / Q000378:metabolism; D013961:Thyroid Gland / Q000378:metabolism / Q000473:pathology / Q000502:physiology*; D013972:Thyrotropin / Q000378:metabolism
D009479:Neuropeptides; D010472:Perchlorates; D017680:Potassium Compounds; C009006:potassium perchlorate; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D013972:Thyrotropin; D013006:Growth Hormone